Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Teaching has always been in opera singer’s genes
2016-12-26

Description: Albertus Engelbrecht Tags: Albertus Engelbrecht 

Albertus Engelbrecht believes that his predecessor
and mentor at the Odeion School of Music ,
Peet van Heerden, prepared him wonderfully for his task
as Vocals lecturer.
Photo: Jóhann Thormählen

He has captivated audiences from Berlin to Los Angeles with his singing talent for 17 years. Yet, teaching has always been in his genes, and as a child Albertus Engelbrecht dreamed about teaching music someday.

Once, when the opera singer stood on the Free State flats during his MMus studies at the University of the Free State (UFS), he knew this is where he would come.

He has been employed as Vocals lecturer at the Odeion School of Music (OSM) since 1 July 2016 and is now ploughing back his knowledge for students he believes have an incredible passion for singing that is not found even in European vocalists.

Concerts in Los Angeles stand out
Engelbrecht was a lyrical tenor at the Landestheater Niederbayern in Passau, Germany, and was working with students as well as professional singers (in Nürnberg and later Passau). However, he was bitten by the teaching bug much earlier. “When I was a student at Stellenbosch (where he obtained his BMus degree at Stellenbosch University), I discovered I had a love for vocals training,” he says.

He has performed all over Europe and worked with famous conductors such as Philipp Augin (Los Angeles Opera). “The most impressive performance was the New Year concerts in Los Angeles, and specifically the concert in the Walt Disney Concert Hall, with fantastic architecture by Frank Gehry, and housing approximately 2 260 people.”

“When I was a student at Stellenbosch, I discovered that I had a love for vocals training.”

Big boots to fill at OSM
He achieved his master’s degree magna summa Cum Laude at the UFS and received the Fanie Beetge prize for the best postgraduate student. He studied for his master’s degree under Peet van Heerden, with Dr Matildie Thom Wium as supervisor.

Following Van Heerden’s retirement, Engelbrecht had big boots to fill. “The most important thing that I learnt from him as mentor was that the instrument of a vocalist is also the body and soul of that individual – to be able to see the human standing, singing before me.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept